Westaim subsidiary Nucryst Pharmaceuticals reports positive drug trials

TORONTO (CP) - Nucryst Pharmaceuticals Corp., a subsidiary of Westaim Corp., said Tuesday initial reports suggest positive results from its drug used to treat a chronic inflammatory skin disease....More